NasdaqGS - Nasdaq Real Time Price USD
Lifecore Biomedical, Inc. (LFCR)
6.38
+0.21
+(3.40%)
At close: April 25 at 4:00:02 PM EDT
6.41
+0.03
+(0.47%)
After hours: April 25 at 5:59:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.09 | -0.31 | -1.33 | -0.7 |
| Low Estimate | -0.1 | -0.32 | -1.34 | -0.79 |
| High Estimate | -0.09 | -0.29 | -1.32 | -0.61 |
| Year Ago EPS | -0.2 | -0.53 | 0.32 | -1.33 |
Revenue Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 35.3M | 25.48M | 127.72M | 132.8M |
| Low Estimate | 34.6M | 25.01M | 127.02M | 128.85M |
| High Estimate | 35.99M | 25.94M | 128.41M | 136.75M |
| Year Ago Sales | 37.89M | 24.7M | 128.26M | 127.72M |
| Sales Growth (year/est) | -6.84% | 3.12% | -0.42% | 3.98% |
Earnings History
| Currency in USD | 5/31/2024 | 8/31/2024 | 11/30/2024 | 2/28/2025 |
|---|---|---|---|---|
| EPS Est. | 0.16 | -0.49 | -0.29 | -0.15 |
| EPS Actual | -0.2 | -0.53 | -0.25 | -0.47 |
| Difference | -0.36 | -0.04 | 0.04 | -0.32 |
| Surprise % | -225.00% | -8.90% | 13.79% | -213.33% |
EPS Trend
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.09 | -0.31 | -1.33 | -0.7 |
| 7 Days Ago | -0.04 | -0.32 | -0.94 | -0.64 |
| 30 Days Ago | -0.04 | -0.32 | -0.94 | -0.64 |
| 60 Days Ago | -0.02 | -0.31 | -0.9 | -0.63 |
| 90 Days Ago | -0.02 | -0.31 | -0.9 | -0.63 |
EPS Revisions
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 2 | -- | -- |
| Up Last 30 Days | -- | 2 | -- | -- |
| Down Last 7 Days | 2 | -- | 2 | 2 |
| Down Last 30 Days | 2 | -- | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LFCR | -418.02% | 22.52% | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
| Reiterates | Stephens & Co.: Equal-Weight to Equal-Weight | 1/3/2025 |
| Maintains | Craig-Hallum: Buy to Buy | 11/22/2024 |
| Initiated | Craig-Hallum: Buy | 9/5/2024 |
| Downgrade | Barrington Research: Outperform to Market Perform | 8/28/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 9/1/2023 |
| Maintains | Stephens & Co.: Equal-Weight to Equal-Weight | 9/1/2023 |
Related Tickers
AMRX Amneal Pharmaceuticals, Inc.
7.48
+0.81%
INDV Indivior PLC
11.56
+7.43%
OPTN OptiNose, Inc.
9.28
+0.22%
BIOA BioAge Labs, Inc.
4.2300
+0.71%
EVO Evotec SE
4.2200
+0.24%
GLAND.BO Gland Pharma Limited
1,451.35
-0.97%
RDY Dr. Reddy's Laboratories Limited
13.79
-1.50%
KMDA Kamada Ltd.
6.69
+1.06%
HLN Haleon plc
10.18
-0.13%
PBH Prestige Consumer Healthcare Inc.
80.54
+1.27%